PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 74 filers reported holding PMV PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 1.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,244,563 | +457.5% | 365,564 | +468.4% | 0.00% | – |
| Q2 2023 | $402,644 | +46.3% | 64,320 | +11.5% | 0.00% | – |
| Q1 2023 | $275,243 | -72.7% | 57,703 | -50.3% | 0.00% | -100.0% |
| Q4 2022 | $1,009,600 | -67.7% | 116,046 | -55.9% | 0.00% | -50.0% |
| Q3 2022 | $3,129,000 | -57.9% | 262,910 | -49.5% | 0.00% | -66.7% |
| Q2 2022 | $7,425,000 | +1175.8% | 521,055 | +1762.6% | 0.01% | – |
| Q1 2022 | $582,000 | -74.5% | 27,974 | -71.7% | 0.00% | -100.0% |
| Q4 2021 | $2,281,000 | +42.0% | 98,738 | +83.2% | 0.00% | 0.0% |
| Q3 2021 | $1,606,000 | -12.1% | 53,885 | +0.8% | 0.00% | 0.0% |
| Q2 2021 | $1,827,000 | +68.2% | 53,479 | +62.0% | 0.00% | 0.0% |
| Q1 2021 | $1,086,000 | +587.3% | 33,020 | +1182.3% | 0.00% | – |
| Q4 2020 | $158,000 | – | 2,575 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 1,614,911 | $9,915,554 | 48.05% |
| OUP Management Co., LLC | 989,232 | $6,073,884 | 13.66% |
| Euclidean Capital LLC | 5,255,286 | $32,267,456 | 3.52% |
| Tri Locum Partners LP | 821,384 | $5,043,298 | 1.61% |
| Ghost Tree Capital, LLC | 705,881 | $4,334,109 | 1.42% |
| Boxer Capital, LLC | 3,163,795 | $19,425,701 | 1.03% |
| Mesirow Financial Investment Management, Inc. | 34,748 | $213,353 | 0.93% |
| Orbimed Advisors | 6,563,077 | $40,297,293 | 0.86% |
| Octagon Capital Advisors LP | 904,000 | $5,550,560 | 0.85% |
| Nextech Invest Ltd. | 421,284 | $2,586,684 | 0.78% |